Do you want to read an article? Please log in or register.
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Pulmonary Hypertension
Related content
Pulmonary Hypertension
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
Lancet Respir Med.
Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, Ross RVM, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Noordegraaf AV, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium
doi: 10.1016/S2213-
Pulmonary Hypertension
Gasometric gradients between blood obtained from the pulmonary artery wedge and pulmonary artery positions in pulmonary arterial hypertension
Respir Res.
Khirfan G, Ahmed MK, Faulx MD, Dakkak W, Dweik RA, Tonelli AR
doi: 10.1186/s12931-018-0969-7.
RECOMMENDED
Pulmonary Hypertension
Selexipag for the treatment of children with pulmonary arterial hypertension: First multicenter experience in drug safety and efficacy
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Heart Lung Transplant.
Hansmann G, Meinel K, Bukova M, Chouvarine P, Wåhlander H, Koestenberger M, European Pediatric Pulmonary Vascular Disease Network (EPPVDN).
doi: 10.1016/j.healun.2020.03.029.
RECOMMENDED
Pulmonary Hypertension
Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Heart Lung Transplant.
DesJardin JT, Kolaitis NA, Kime N, Kronmal RA, Benza RL, Elwing JM, Lammi MR, McConnell JW, Presberg KW, Sager JS, Shlobin OA, De Marco T, PHAR Investigators (2).
doi: 10.1016/j.healun.2020.05.005.
RECOMMENDED
Pulmonary Hypertension
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
Respir Res.
Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E
doi: 10.1186/s12931-018-0957-y.
RECOMMENDED
Pulmonary Hypertension
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
Eur Respir J.
Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, Ivy DD, Berger RMF
doi: 10.1183/13993003.
RECOMMENDED
Pulmonary Hypertension
Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Kriechbaum SD, Rudolph F, Wiedenroth CB, Mielzarek L, Haas M, Guth S, Hamm CW, Mayer E, Liebetrau C, Keller T
doi: 10.1186/s12931-020-01472-3.
COPDPneumonia
Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention
Eur J Cardiothorac Surg.
Andell P, Sjögren J, Batra G, Szummer K, Koul S
doi: 10.1093/ejcts/ezx219.
Pulmonary Hypertension
Pulmonary hypertension associated with chronic lung diseases
Swiss Med Wkly.
Funke M, Geiser T, Schoch OD
doi: 10.4414/smw.2016.14363.